Vimian

Since 2015, by partnering with strong entrepreneurs and management teams of a select number of market leading businesses within Specialty Pharma (Nextmune), Diagnostics (Indical Bioscience), Veterinary Services (VetFamily) and MedTech (Movora), targeting the companion and production animal health market, Fidelio has determinedly been building the foundation of what today is known as Vimian.

Vimian is a global and fast-growing group of innovation-driven companies that share a passion for making a positive impact through improving animal health. The group puts science, technology and its customers’ needs at the centre of everything it does to deliver effective solutions to animals and veterinary professionals around the world.

Vimian brings together pioneering and entrepreneurial businesses in animal health, with an aim to create a uniquely diversified proposition of products and services of the highest standard. The group provides individual businesses with access to its networks, expertise, infrastructure and capital to accelerate innovation and growth.

Headquartered in Stockholm, Sweden, Vimian and its family of companies currently serve more than 15,000 customers in +70 countries, employ over 400 people and have a combined turnover of approximately EUR 140m.

Specialty Pharma – Nextmune

Nextmune is a science-driven, global specialty pharma company dedicated to improving health for dogs, cats and horses, focusing on allergy and dermatology as well as specialized care and nutrition. The product offering encompasses diagnostics, prescription and non-prescription products and is offered to veterinarians and pet parents in more than 70 countries worldwide. Nextmune was created by Fidelio through the acquisitions and mergers of seven companies in the Netherlands, Spain, Belgium, Norway, the U.S. and Italy between 2015 and 2020. For more information, please visit: www.nextmune.com.

Diagnostics – Indical Bioscience

Indical Bioscience is an innovative provider of molecular and immuno diagnostics solutions to the veterinary market. For over two decades, its dedicated team of scientists and veterinary professionals has redefined reliability within diagnostic testing. Its customers play a central role in protecting the health of animals and humans worldwide. In 2019, Fidelio acquired Indical Bioscience through a carve-out from Qiagen, a molecular diagnostics group listed on the NYSE and Frankfurt stock exchanges. For more information, please visit: www.indical.com.

Veterinary Services – VetFamily

VetFamily is one of the leading service platforms for independent veterinary clinics, representing one of the largest veterinary communities globally. VetFamily makes it possible for veterinarians to remain independent, while benefiting from tech-enabled services supporting joint procurement and marketing, digitalization, knowledge sharing and business development. Fidelio acquired VetFamily in 2019. For more information, please visit: www.vetfamily.com.

MedTech – Movora

Movora is a leading provider of solutions within veterinary orthopedics, with a foundation built on three decades of advancements in animal mobility. By bringing together key leaders in veterinary medical technology, it delivers a broad range of innovative products and progressive customer solutions. Movora was created by Fidelio through the acquisition of three companies located in Switzerland and the U.S. during 2019 and 2020. For more information, please visit: www.movora.com.